| Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism T Farge, E Saland, F De Toni, N Aroua, M Hosseini, R Perry, C Bosc, ... Cancer discovery 7 (7), 716-735, 2017 | 807 | 2017 |
| Interaction of platelet-derived autotaxin with tumor integrin αVβ3 controls metastasis of breast cancer cells to bone R Leblanc, SC Lee, M David, JC Bordet, DD Norman, R Patil, D Miller, ... Blood, The Journal of the American Society of Hematology 124 (20), 3141-3150, 2014 | 176 | 2014 |
| Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts M David, E Wannecq, F Descotes, S Jansen, B Deux, J Ribeiro, CM Serre, ... PloS one 5 (3), e9741, 2010 | 151 | 2010 |
| Proteasome inhibitors induce FLT3-ITD degradation through autophagy in AML cells C Larrue, E Saland, H Boutzen, F Vergez, M David, C Joffre, MA Hospital, ... Blood, The Journal of the American Society of Hematology 127 (7), 882-892, 2016 | 137 | 2016 |
| Dendrogenin A drives LXR to trigger lethal autophagy in cancers G Segala, M David, P De Médina, MC Poirot, N Serhan, F Vergez, ... Nature communications 8 (1), 1903, 2017 | 105 | 2017 |
| Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia H Boutzen, E Saland, C Larrue, F De Toni, L Gales, FA Castelli, ... Journal of Experimental Medicine 213 (4), 483-497, 2016 | 87 | 2016 |
| Targeting lysophosphatidic acid receptor type 1 with Debio 0719 inhibits spontaneous metastasis dissemination of breast cancer cells independently of cell proliferation and … M David, J Ribeiro, F Descotes, CM Serre, M Barbier, M Murone, ... International journal of oncology 40 (4), 1133-1141, 2012 | 71 | 2012 |
| Lysophosphatidic acid receptor type 1 (LPA1) plays a functional role in osteoclast differentiation and bone resorption activity M David, I Machuca-Gayet, J Kikuta, P Ottewell, F Mima, R Leblanc, ... Journal of Biological Chemistry 289 (10), 6551-6564, 2014 | 56 | 2014 |
| Preclinical assessment of antigen-specific chimeric antigen receptor regulatory T cells for use in solid organ transplantation E Proics, M David, M Mojibian, M Speck, N Lounnas-Mourey, ... Gene Therapy 30 (3), 309-322, 2023 | 41 | 2023 |
| Pleiotropic activity of lysophosphatidic acid in bone metastasis O Peyruchaud, R Leblanc, M David Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2013 | 41 | 2013 |
| Characterization of a sphingosine 1-phosphate receptor antagonist prodrug PC Kennedy, R Zhu, T Huang, JL Tomsig, TP Mathews, M David, ... Journal of Pharmacology and Experimental Therapeutics 338 (3), 879-889, 2011 | 39 | 2011 |
| Identification of Heparin-Binding EGF-Like Growth Factor (HB-EGF) as a Biomarker for Lysophosphatidic Acid Receptor Type 1 (LPA1) Activation in Human Breast … M David, D Sahay, F Mege, F Descotes, R Leblanc, J Ribeiro, P Clézardin, ... PLoS One 9 (5), e97771, 2014 | 31 | 2014 |
| IL23R-specific CAR Tregs for the treatment of Crohn’s disease Y Cui, M David, L Bouchareychas, S Rouquier, S Sajuthi, M Ayrault, ... Journal of Crohn's and Colitis, jjae135, 2024 | 5 | 2024 |
| Cytosine arabinoside chemotherapy does not enrich for leukemic stem cells in xenotransplantation model of human acute myeloid leukemia F de Toni, RL Perry, E Saland, M Sugita, M David, F Vergez, E Delabesse, ... Blood 122 (21), 1651, 2013 | 2 | 2013 |
| Epigenetic control of multiple genes with a lentiviral vector encoding transcriptional repressors fused to compact zinc finger arrays D Monteferrario, M David, SK Tadi, Y Zhou, I Marchetti, C Jeanneau, ... Molecular Therapy Methods & Clinical Development 32 (2), 2024 | 1 | 2024 |
| OP02 IL23R-CAR-Tregs: creating a therapeutic breakthrough for Crohn’s Disease Y Cui, S Boulakirba, M David, L Bouchareychas, S Rouquier, S Sajuthi, ... Journal of Crohn's and Colitis 18 (Supplement_1), i3-i3, 2024 | 1 | 2024 |
| Production of therapeutic levels of human FIX-R338L by engineered B cells using GMP-compatible medium M David, D Monteferrario, G Saviane, C Jeanneau, I Marchetti, CF Dupont, ... Molecular Therapy-Methods & Clinical Development 31, 2023 | 1 | 2023 |
| IL23R-CAR-Tregs–a novel approach to treat Crohn's disease (CD) patients J Gertner-Dardenne, T Abel, S Boulakirba, D Fenard, C Dumont, M David, ... ESGCT Collaborative Virtual Congress 19À22 October 2021 Abstracts. Human …, 2021 | 1 | 2021 |
| Interaction of autotaxin with breast cancer cell integrins might contribute to lysophosphatidic acid-mediated bone metastases M David, R Leblanc, B Deux, CM Serre, J Ribeiro, P Clézardin, ... Bone 1 (48), S39-S40, 2011 | 1 | 2011 |
| Expression of lyosophospholipase D/autotaxin by breast cancer cells controls bone metastasis formation by increasing osteoclast differentiation M David, E Wannecq, S Jansen, B Deux, J Ribeiro, CM Serre, S Grès, ... Bone, S41, 2010 | 1 | 2010 |
